Key Financial Data Of Reporting Company

COSMOS Pharmaceutical Corporation - Filing #7310433

Concept 2023-06-01 to
2024-05-31
As at
2024-05-31
2023-06-01 to
2024-05-31
As at
2024-05-31
As at
2023-05-31
As at
2023-05-31
2022-06-01 to
2023-05-31
2022-06-01 to
2023-05-31
2021-06-01 to
2022-05-31
2021-06-01 to
2022-05-31
As at
2022-05-31
As at
2022-05-31
2020-06-01 to
2021-05-31
As at
2021-05-31
2020-06-01 to
2021-05-31
As at
2021-05-31
2019-06-01 to
2020-05-31
As at
2020-05-31
As at
2020-05-31
2019-06-01 to
2020-05-31
Key financial data of reporting company
Business results of reporting company
Net sales
964,989,000,000 JPY
964,988,000,000 JPY
827,697,000,000 JPY
827,696,000,000 JPY
755,414,000,000 JPY
755,413,000,000 JPY
726,424,000,000 JPY
726,423,000,000 JPY
684,403,000,000 JPY
684,402,000,000 JPY
Ordinary profit (loss)
34,299,000,000 JPY
34,286,000,000 JPY
33,086,000,000 JPY
33,070,000,000 JPY
32,861,000,000 JPY
32,839,000,000 JPY
35,835,000,000 JPY
35,817,000,000 JPY
31,562,000,000 JPY
31,544,000,000 JPY
Profit (loss)
24,446,000,000 JPY
23,787,000,000 JPY
23,141,000,000 JPY
27,145,000,000 JPY
21,423,000,000 JPY
Share capital
4,178,000,000 JPY
4,178,000,000 JPY
4,178,000,000 JPY
4,178,000,000 JPY
4,178,000,000 JPY
Total number of issued shares
40,000,800 xbrli:shares
40,000,800 xbrli:shares
40,000,800 xbrli:shares
40,000,800 xbrli:shares
20,000,400 xbrli:shares
Net assets
230,926,000,000 JPY
231,442,000,000 JPY
211,072,000,000 JPY
210,626,000,000 JPY
190,507,000,000 JPY
190,106,000,000 JPY
170,578,000,000 JPY
170,235,000,000 JPY
145,366,000,000 JPY
145,675,000,000 JPY
Total assets
476,150,000,000 JPY
476,546,000,000 JPY
420,967,000,000 JPY
420,554,000,000 JPY
363,052,000,000 JPY
362,630,000,000 JPY
341,318,000,000 JPY
340,892,000,000 JPY
319,854,000,000 JPY
320,283,000,000 JPY
Net assets per share
5,827.23
5,840.26
5,330.26
5,319.00
4,810.92
4,800.79
4,307.63
4,298.96
3,670.96
3,678.76
Dividend paid per share
120.00
100.00
80.00
70.00
110.00
Interim dividend paid per share
60.00
42.50
40.00
27.50
50.00
Basic earnings (loss) per share
617.22
617.02
600.96
600.71
584.76
584.40
685.80
685.52
541.30
541.01
Diluted earnings per share
Equity-to-asset ratio
0.485 xbrli:pure
0.486 xbrli:pure
0.501 xbrli:pure
0.501 xbrli:pure
0.525 xbrli:pure
0.524 xbrli:pure
0.500 xbrli:pure
0.499 xbrli:pure
0.454 xbrli:pure
0.455 xbrli:pure
Rate of return on equity
0.111 xbrli:pure
0.111 xbrli:pure
0.119 xbrli:pure
0.119 xbrli:pure
0.128 xbrli:pure
0.128 xbrli:pure
0.172 xbrli:pure
0.172 xbrli:pure
0.158 xbrli:pure
0.158 xbrli:pure
Price-earnings ratio
20.6 xbrli:pure
20.6 xbrli:pure
22.1 xbrli:pure
22.1 xbrli:pure
20.9 xbrli:pure
20.9 xbrli:pure
22.2 xbrli:pure
22.2 xbrli:pure
28.6 xbrli:pure
28.6 xbrli:pure
Payout ratio
0.194 xbrli:pure
0.166 xbrli:pure
0.137 xbrli:pure
0.102 xbrli:pure
0.102 xbrli:pure
Net cash provided by (used in) operating activities
55,175,000,000 JPY
54,434,000,000 JPY
32,194,000,000 JPY
27,875,000,000 JPY
65,461,000,000 JPY
Net cash provided by (used in) investing activities
-57,329,000,000 JPY
-49,113,000,000 JPY
-43,717,000,000 JPY
-19,381,000,000 JPY
-26,956,000,000 JPY
Net cash provided by (used in) financing activities
8,527,000,000 JPY
3,245,000,000 JPY
-6,222,000,000 JPY
-5,507,000,000 JPY
-5,405,000,000 JPY
Cash and cash equivalents
52,301,000,000 JPY
45,928,000,000 JPY
37,362,000,000 JPY
55,108,000,000 JPY
52,122,000,000 JPY
Number of employees
5,504 xbrli:pure
5,512 xbrli:pure
5,290 xbrli:pure
5,282 xbrli:pure
5,101 xbrli:pure
5,093 xbrli:pure
4,872 xbrli:pure
4,864 xbrli:pure
4,378 xbrli:pure
4,386 xbrli:pure
Average number of temporary employees
21,719 xbrli:pure
21,756 xbrli:pure
18,898 xbrli:pure
18,857 xbrli:pure
17,199 xbrli:pure
17,156 xbrli:pure
16,167 xbrli:pure
16,122 xbrli:pure
14,628 xbrli:pure
14,678 xbrli:pure
Total shareholder return
1.529 xbrli:pure
1.581 xbrli:pure
1.446 xbrli:pure
1.790 xbrli:pure
1.809 xbrli:pure
Total return on share price index
2.070 xbrli:pure
1.554 xbrli:pure
1.358 xbrli:pure
1.333 xbrli:pure
1.062 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.